Abstract | DESIGN: Retrospective comparative study. OBJECTIVE: The purpose of this study is to measure SSI outcomes before and after implementation of our center's multidisciplinary clinical pathway protocol for high-risk spinal surgery. BACKGROUND:
Surgical site infections (SSIs) after spinal fusion harm patients and are associated with significant health care costs. Given the high rate of SSI in neuromuscular populations, there is a rationale to develop infection prevention strategies. METHODS: An institutional clinical pathway was created in 2012 and based on nationally published Best Practice Guidelines as well as hospital practices with a goal of reducing the rate of deep SSI in high-risk patients. Patient and procedure characteristics were compared prior to (2008-2011) and after (2012-2016) implementation of the pathway. Logistic regression using penalized maximum likelihood was used to assess differences in rate of infection before and after implementation. RESULTS: Cohorts of 132 and 115 high-risk patients were analyzed before and after pathway implementation. Rate of deep infections decreased from 8% to 1% of patients (p = .005). Preoperative antibiotics were dosed within 1 hour in 90% of the postpathway cohort. Redosing was successful in 94% of patients for first redose and 79% for second redose. Betadine irrigation was used in 76% of cases and vancomycin administered in 86%. Multivariable analysis determined that instances of compliant antibiotics dosing had 63% lower odds of infection compared with instances of noncompliance (p = .04). CONCLUSIONS: Implementation of a multidisciplinary pathway aimed to reduce infection in patients at high risk for SSI after spinal fusion led to a significant reduction in deep SSI rate. It is impossible to attribute the drop in the deep SSI rate to any one factor. Our results demonstrate that adherence to a protocol using multiple strategies to reduce infection results in a lower SSI rate, lower care costs, and improved patient-related outcomes. LEVEL OF EVIDENCE: Level III.
|
Authors | Michael Glotzbecker, Michael Troy, Patricia Miller, Jay Berry, Lara Cohen, Alexandra Gryzwna, Mary Ellen McCann, M Timothy Hresko, Susan Goobie, John Emans, Robert Brustowitz, Brian Snyder, Daniel Hedequist |
Journal | Spine deformity
(Spine Deform)
Vol. 7
Issue 1
Pg. 33-39
(01 2019)
ISSN: 2212-1358 [Electronic] England |
PMID | 30587318
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2018 Scoliosis Research Society. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Vancomycin
- Povidone-Iodine
|
Topics |
- Adolescent
- Antibiotic Prophylaxis
(methods)
- Critical Pathways
- Female
- Humans
- Logistic Models
- Male
- Patient Care Team
- Povidone-Iodine
(therapeutic use)
- Retrospective Studies
- Risk Factors
- Spinal Fusion
(adverse effects)
- Surgical Wound Infection
(prevention & control)
- Vancomycin
(therapeutic use)
|